A proposed role for prostaglandins in the modulation of the relaxation response to urotensin I in isolated rat arteries.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects; D001241:Aspirin / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009126:Muscle Relaxation / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D011738:Pyrilamine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014579:Urotensins / Q000494:pharmacology*
D001095:Arachidonic Acids; D010455:Peptides; D011453:Prostaglandins; D014579:Urotensins; D016718:Arachidonic Acid; D001285:Atropine; C029676:urotensin I; D011433:Propranolol; D011738:Pyrilamine; D001241:Aspirin; D009638:Norepinephrine; D007213:Indomethacin